23.35
price up icon0.56%   0.13
after-market Dopo l'orario di chiusura: 23.35
loading
Precedente Chiudi:
$23.22
Aprire:
$23.17
Volume 24 ore:
969.95K
Relative Volume:
1.00
Capitalizzazione di mercato:
$1.55B
Reddito:
$9.98M
Utile/perdita netta:
$-154.08M
Rapporto P/E:
-9.0504
EPS:
-2.58
Flusso di cassa netto:
$-159.66M
1 W Prestazione:
+4.19%
1M Prestazione:
+8.81%
6M Prestazione:
-2.79%
1 anno Prestazione:
-46.76%
Intervallo 1D:
Value
$22.52
$23.50
Intervallo di 1 settimana:
Value
$21.71
$24.05
Portata 52W:
Value
$14.40
$47.00

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Name
Nome
Celldex Therapeutics Inc
Name
Telefono
908-200-7500
Name
Indirizzo
53 FRONTAGE ROAD, HAMPTON
Name
Dipendente
186
Name
Cinguettio
@search?q=celldex
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
CLDX's Discussions on Twitter

Confronta CLDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLDX
Celldex Therapeutics Inc
23.35 1.54B 9.98M -154.08M -159.66M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-28 Iniziato Canaccord Genuity Buy
2025-03-20 Iniziato Morgan Stanley Overweight
2025-02-13 Iniziato UBS Buy
2024-10-07 Iniziato Citigroup Buy
2024-09-30 Iniziato Goldman Neutral
2024-09-27 Downgrade Wolfe Research Outperform → Peer Perform
2024-06-18 Iniziato Stifel Buy
2024-06-11 Iniziato Wolfe Research Outperform
2023-12-20 Iniziato TD Cowen Outperform
2023-11-10 Aggiornamento Wells Fargo Underweight → Equal Weight
2023-08-22 Iniziato Wells Fargo Underweight
2021-09-17 Iniziato Jefferies Buy
2021-09-10 Iniziato SVB Leerink Outperform
2021-07-22 Iniziato Guggenheim Buy
2020-02-21 Iniziato Cantor Fitzgerald Overweight
2017-08-01 Ripresa H.C. Wainwright Buy
2016-11-07 Iniziato Aegis Capital Buy
2016-03-08 Downgrade Jefferies Buy → Hold
2016-03-07 Downgrade Guggenheim Buy → Neutral
2016-03-07 Downgrade Leerink Partners Outperform → Mkt Perform
2016-03-07 Downgrade Wedbush Outperform → Neutral
2016-03-01 Iniziato H.C. Wainwright Buy
2015-08-11 Reiterato Brean Capital Buy
2015-08-11 Reiterato Oppenheimer Outperform
2015-08-11 Reiterato ROTH Capital Buy
2015-06-02 Reiterato WBB Securities Strong Buy
2014-11-17 Reiterato ROTH Capital Buy
2014-03-04 Reiterato Oppenheimer Outperform
2013-07-08 Reiterato Cantor Fitzgerald Buy
2013-03-08 Reiterato Cantor Fitzgerald Buy
2013-02-26 Reiterato Oppenheimer Outperform
2013-01-10 Reiterato Cantor Fitzgerald Buy
2012-10-02 Reiterato Oppenheimer Outperform
2012-09-14 Reiterato Cantor Fitzgerald Buy
Mostra tutto

Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie

pulisher
Jul 26, 2025

Why Celldex Therapeutics Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Celldex Therapeutics Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Celldex Therapeutics Inc. stock priceFree Investment Risk Control - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Celldex Therapeutics Inc. stockConsistently superior profits - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Celldex Therapeutics Inc. a good long term investmentRapidly expanding wealth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 18, 2025

Is Celldex Therapeutics Inc. stock a good hedge against inflationFree Short-Term Stock Picks - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Celldex Therapeutics Inc. stock price move sharplySafety First Trading Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Celldex Therapeutics Inc. stock performs during market volatility2x Return Forecast - beatles.ru

Jul 15, 2025
pulisher
Jul 08, 2025

Celldex Therapeutics (NASDAQ:CLDX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Jul 08, 2025
pulisher
Jul 03, 2025

B-cell Non-hodgkin Lymphoma Clinical Trials, Companies, - openPR.com

Jul 03, 2025
pulisher
Jun 27, 2025

Cholera Vaccines Market Deep Research and Growth in Future Scope - openPR.com

Jun 27, 2025
pulisher
Jun 25, 2025

Is Celldex Therapeutics, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 24, 2025

(06/24/25) CLDX: A Promising Biotech Name Targeting CSU - moneyshow.com

Jun 24, 2025
pulisher
Jun 23, 2025

Chronic spontaneous urticaria improvements persist 28 weeks after barzolvolimab stopped - Healio

Jun 23, 2025
pulisher
Jun 16, 2025

Celldex stock price target maintained at $50 by H.C. Wainwright - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

Global Personalized Cancer Vaccine Market | Immunotherapy - openPR.com

Jun 16, 2025

Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):